TGFB1 and breast carcinoma: Moreover, if a systemic effect cannot be discarded, our results strongly suggest that a combined approach with DMA and SB431542 at low doses can effectively impair breast cancer metastasis by further improving the inhibition of the TGF-β signaling in primary tumors (Fig. 9).